ANGONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends May 31

ANGIODYNAMICS INC

Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 8, 2026

$11.39+0.15 (+1.33%)

Close on Oct 19, 2026

Market cap: $478.63M
P/E (TTM): –
Dividend yield: –

ANGIODYNAMICS INC cash flow statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2026 2026-05-31	FY 2025 2025-05-31	FY 2024 2024-05-31	FY 2023 2023-05-31	FY 2022 2022-05-31	FY 2021 2021-05-31	FY 2020 2020-05-31	FY 2019 2019-05-31	FY 2018 2018-05-31	FY 2017 2017-05-31	FY 2016 2016-05-31	FY 2015 2015-05-31	FY 2014 2014-05-31	FY 2013 2013-05-31	FY 2012 2012-05-31	FY 2011 2011-05-31	FY 2010 2010-05-31
Depreciation & Amortization	23	26	28	31	29	26	24	26	23	25	28	30	28	27	15	13	12
Stock-Based Compensation	14	9.77	11	11	11	8.63	7.59	9.25	7.91	6.18	3.24	6.00	5.50	4.61	4.05	4.61	4.88
Deferred Income Taxes	0.14	-0.99	-7.97	-2.31	-3.71	-4.81	-1.57	-3.97	-11	-7.65	40	-5.12	2.72	0.83	-0.69	-0.91	5.88
Other Non-Cash Items	-1.97	-0.29	0.06	0.51	0.09	0.15	-0.09	0.01	0.61	0.59	-0.09	-0.18	-0.13	-0.16	-1.15	-0.06	-0.06
Change in Accounts Receivable	-5.75	0.02	7.89	-1.30	-17	-4.16	12	-3.18	5.04	8.48	3.13	2.10	-15	1.02	-2.40	2.77	-2.61
Change in Inventory	10	-1.35	-9.41	-8.20	-2.80	12	-19	-1.43	5.74	0.69	12	-5.65	-6.11	-1.91	-1.52	1.42	7.43
Change in Accounts Payable	-5.83	-16	28	2.14	3.91	4.88	-15	5.21	-7.09	19	-2.96	-6.25	6.79	-9.71	6.58	-2.43	1.52
Operating Cash Flow	3.09	-10	-28	0.08	-7.19	24	-15	37	41	56	45	26	25	27	12	34	40
Capital Expenditures	-2.58	-4.46	-2.52	-3.81	-4.30	-5.19	-7.24	-3.12	-2.39	-3.00	-2.33	-11	-11	-12	-2.49	-2.96	-5.04
Acquisitions	–	–	–	–	–	–	–	–	–	–	–	–	–	–	-238	-1.09	-5.41
Divestitures	0	0	135	0	0	0	0	169	0	0	–	–	–	–	–	–	–
Purchase of Investments	–	–	–	–	–	–	–	–	–	–	0	0	-0.03	-5.13	-124	-168	-42
Sale & Maturity of Investments	–	–	–	–	–	0	0	1.35	0	0.45	0.03	0	0.35	17	194	124	41
Other Investing Activities	–	–	–	–	–	–	–	–	0	0	-2.00	0	0	0.80	-4.00	-0.18	–
Investing Cash Flow	-5.95	-10	124	-9.75	-19	-14	-63	83	-3.66	-2.55	-7.57	-13	-16	-22	-176	-49	-12
Dividends Paid	–	–	–	–	–	–	–	–	–	–	–	–	0	0	0	–	–
Share Repurchases	0	-1.67	0	0	–	–	–	0	0	-14	0	0	0	0	-2.10	–	–
Debt Issued	–	–	–	–	–	–	–	0	0	116	0	15	146	0	150	–	–
Debt Repaid	0	0	-50	-45	0	-20	-133	-15	-5.00	-140	-16	-20	-146	-7.50	-6.55	-0.26	-0.27
Financing Cash Flow	0.56	-0.26	-64	25	7.68	-17	-95	34	-12	-38	-24	-10	-14	-6.29	142	1.92	2.72
Foreign Exchange Rate Adjustments	0.27	0.40	0.13	0.04	-0.52	0.33	-0.07	-0.38	0.47	0	-0.04	-0.20	0.09	-0.07	0.05	0.05	-0.05
Net Change in Cash	-2.03	-20	31	16	-19	-6.27	-173	154	27	15	14	2.29	-5.70	-1.94	-22	-13	31
Free Cash Flow	0.51	-15	-31	-3.73	-11	19	-22	34	39	53	43	14	14	15	9.11	31	35
Income Taxes Paid	0.41	0.80	0.46	0.34	0.33	0.31	0.68	0.43	0.04	-0.10	0.33	0.70	0.18	0.20	2.83	0.83	4.56
Interest Paid	0.43	0.19	0	2.58	0.56	0.73	0.41	5.12	3.19	2.97	3.06	3.15	3.59	4.94	0.44	0.48	0.45

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Aug 31, 2026

Profitability, TTM

Gross margin: 55.7%
Operating margin: -11.2%
Net margin: -10.1%
Return on equity, FY2026: -20.8%

Financial strength

Current ratio: 2.40
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 56.9%

Valuation

P/E ratio: –
Price to sales: 1.47
Price to book: 2.92
Dividend yield: –